A systematic review and economic model of the effectiveness and ...

TABLE 103 Results of the economic model using all response rates estimated on clinician-rated scales
© Queen’s Printer and Controller of HMSO 2006. All rights reserved.
Health Technology Assessment 2006; Vol. 10: No. 23
Strategy Order of treatments received CGI-I scale baseline CGI-S scale baseline
Cost (£) QALY ICER (£) Cost (£) QALY ICER (£)
1 IR-MPH – ATX – DEX – no treatment 1,223 0.8322 D 1,239 0.8244 D
2 ER-MPH8 – ATX – DEX – no treatment 1,468 0.8315 D 1,413 0.8230 D
3 ER-MPH12 – ATX – DEX – no treatment 1,507 0.8328 D 1,456 0.8261 D
4 ATX – IR-MPH – DEX – no treatment 1,496 0.8319 D 1,378 0.8238 D
5 ATX – ER-MPH8 – DEX – no treatment 1,569 0.8315 D 1,460 0.8229 D
6 ATX – ER-MPH12 – DEX – no treatment 1,598 0.8321 D 1,510 0.8250 D
7 IR-MPH – DEX – ATX – no treatment 1,119 0.8326 D 1,140 0.8254 D
8 ER-MPH8 – DEX – ATX – no treatment 1,341 0.8320 D 1,293 0.8242 D
9 ER-MPH12 – DEX – ATX – no treatment 1,426 0.8331 D 1,378 0.8269 D
10 ATX – DEX – IR-MPH – no treatment 1,478 0.8322 D 1,356 0.8247 D
11 ATX – DEX – ER-MPH8 – no treatment 1,488 0.8320 D 1,378 0.8241 D
12 ATX – DEX – ER-MPH12 – no treatment 1,491 0.8324 D 1,387 0.8256 D
13 DEX – IR-MPH – ATX – no treatment 1,065 0.8334 – 1,102 0.8267 –
14 DEX – ER-MPH8 – ATX – no treatment 1,098 0.8332 D 1,142 0.8260 D
15 DEX – ER-MPH12 – ATX – no treatment 1,102 0.8337 177,000 1,150 0.8278 46,000
16 DEX – ATX – IR-MPH – no treatment 1,101 0.8334 D 1,131 0.8266 D
17 DEX – ATX – ER-MPH8 – no treatment 1,111 0.8332 D 1,153 0.8260 D
18 DEX – ATX – ER-MPH12 – no treatment 1,114 0.8336 D 1,162 0.8275 D
19 No treatment 1,225 0.7741 D 1,224 0.7727 D
D, dominated.
TABLE 104 Results of the economic model using all response rates defined on CGI-I, CGI-S, ADHD-RS or SNAP-IV
Strategy Order of treatments received CGI-I scale baseline ADHD-RS scale baseline
Cost (£) QALY ICER (£) Cost (£) QALY ICER (£)
1 IR-MPH – ATX – DEX – no treatment 1,240 0.8304 D 1,225 0.8316 D
2 ER-MPH8 – ATX – DEX – no treatment 1,449 0.8298 D 1,464 0.8312 D
3 ER-MPH12 – ATX – DEX – no treatment 1,492 0.8317 D 1,507 0.8324 D
4 ATX – IR-MPH – DEX – no treatment 1,444 0.8301 D 1,487 0.8313 D
5 ATX – ER-MPH8 – DEX – no treatment 1,527 0.8298 D 1,565 0.8311 D
6 ATX – ER-MPH12 – DEX – no treatment 1,568 0.8308 D 1,596 0.8316 D
7 IR-MPH – DEX – ATX – no treatment 1,117 0.8311 D 1,115 0.8321 D
8 ER-MPH8 – DEX – ATX – no treatment 1,312 0.8306 D 1,339 0.8318 D
9 ER-MPH12 – DEX – ATX – no treatment 1,405 0.8322 D 1,424 0.8328 D
10 ATX – DEX – IR-MPH – no treatment 1,423 0.8308 D 1,467 0.8317 D
11 ATX – DEX – ER-MPH8 – no treatment 1,435 0.8306 D 1,475 0.8316 D
12 ATX – DEX – ER-MPH12 – no treatment 1,439 0.8312 D 1,478 0.8319 D
13 DEX – IR-MPH – ATX – no treatment 1,068 0.8325 – 1,059 0.8333 –
14 DEX – ER-MPH8 – ATX – no treatment 1,096 0.8323 D 1,082 0.8331 D
15 DEX – ER-MPH12 – ATX – no treatment 1,101 0.8330 63,690 1,085 0.8335 108,747
16 DEX – ATX – IR-MPH – no treatment 1,095 0.8325 D 1,083 0.8332 D
17 DEX – ATX – ER-MPH8 – no treatment 1,106 0.8323 D 1,091 0.8331 D
18 DEX – ATX – ER-MPH12 – no treatment 1,111 0.8329 D 1,094 0.8334 D
19 No treatment 1,225 0.7739 D 1,227 0.7735 D
D, dominated.
121